|
"jia horng kao"的相關文件
顯示項目 906-915 / 1180 (共118頁)
<< < 86 87 88 89 90 91 92 93 94 95 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T08:44:44Z |
HBV/A and HBV/C genotype predominance among patients with chronic hepatitis B virus infection in Cebu City, Philippines
|
Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen; 陳定信; 劉振驊; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 曾岱宗;高嘉宏; Batoctoy, K.S. and Tseng, T.-C. and Kao, J.-H. and Quiza, F.E. and Garcia Sr., L.H. and Lao-Tan, J.; Batoctoy, Karen S.; Tseng, Tai-Chung; Kao, Jia-Horng; Quiza, Fidelis E.; Garcia, Lamberto H.; Lao-Tan, Judy; Cheng, Huei-Ru; JIA-HORNG KAO; Kao, Jia-Horng; Batoctoy, Karen S.; Wu, Hui-Lin; Tseng, Tai-Chung; Liu, Chen-Hua; Kao, Jia-Horng; Yang, Hung-Chih; Lao-Tan, Judy; Quiza, Fidelis E.; Su, Tung-Hung; Garcia, Lamberto H. |
| 臺大學術典藏 |
2018-09-10T08:44:44Z |
Hepatitis C virus and lipid profiles: More questions than answers?
|
Hsu, Ching-Sheng;Kao, Jia-Horng; HSU, CHING-SHENG;KAO, JIA-HORNG; 許景盛;高嘉宏; JIA-HORNG KAO; Hsu, Ching-Sheng; Liu, Wei-Liang; HSU, CHING-SHENG; Chao, You-Chen; KAO, JIA-HORNG; Lin, Hans Hsienhong; Tseng, Tai-Chung; Wang, Chia-Chi; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信 |
| 臺大學術典藏 |
2018-09-10T08:44:44Z |
Hepatitis during antituberculosis treatment
|
Wu, Li-Wei; Kao, Jia-Horng; JIA-HORNG KAO; Wu, Li-Wei; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T08:44:44Z |
Il-28b predicts response to chronic hepatitis C therapy -fine-mapping and replication study in Asian populations
|
Ochi, H.; Maekawa, T.; Abe, H. ;Hayashida, Y.; Nakano, R.; Imamura, M. ;Hiraga, N. ;Kawakami, Y. ;Aimitsu, S.; Kao, J.H. ;Tsunoda, M.K.; Tsunoda, T.; Kumada, H.; Nakamura, Y.; Hayes, N.C. ;Chayama, K.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:44:43Z |
Boceprevir for chronic HCV genotype 1 infection [2]
|
Hsu, C.-S. ;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:44:43Z |
Entecavir: A review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease
|
Keating, G.M.; Buti, M.; Gadano, A. ;Kao, J.-H. ;Lee, C.-M.; Peng, C.-Y.; Schiff, E.R.; Tanwandee, T.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:44:32Z |
Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses
|
Yeh, M.-L.; Hung, C.-H.; Huang, J.-F.; Liu, C.-J.; Lee, C.-M.; Dai, C.-Y.; Wang, J.-H.; Lin, Z.-Y.; Lu, S.-N.; Hu, T.-H.; Yu, M.-L.; Kao, J.-H.; Chuang, W.-L.; Chen, P.-J.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:44:32Z |
Reply to Guedj et al.: Early transient increase of hepatitis C virus viral load in genotype 1 and 2 infections, and the use of mathematical modeling
|
Hsu, Ching-Sheng;Jeng, Jenher;Kao, Jia-Horng;Chen, Ding-Shinn; DING-SHINN CHEN; JIA-HORNG KAO; HSU, CHING-SHENG; JENG, JENHER; KAO, JIA-HORNG; CHEN, DING-SHINN |
| 臺大學術典藏 |
2018-09-10T08:41:24Z |
Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: Genotype B vs C
|
Liu, C.-J. ;Cheng, H.-R.; Chen, C.-L.; Chen, T.-C.; Tseng, T.-C.; Wang, Z.-L. ;Chen, P.-J. ;Liu, C.-H. ;Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:38:36Z |
Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients
|
Liu, C.-H. ;Liang, C.-C. ;Huang, K.-W.; Liu, C.-J. ;Chen, S.-I.; Lin, J.-W. ;Hung, P.-H.; Tsai, H.-B. ;Lai, M.-Y. ;Chen, P.-J. ;Chen, J.-H. ;Chen, D.-S. ;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; HUNG-BIN TSAI; CHEN-HUA LIU; DING-SHINN CHEN; KAI-WEN HUANG; JIA-HORNG KAO |
顯示項目 906-915 / 1180 (共118頁)
<< < 86 87 88 89 90 91 92 93 94 95 > >>
每頁顯示[10|25|50]項目
|
